Thomas Engellenner

Thomas Engellenner

Pepper Hamilton LLP

Contact  |  View Bio  |  RSS

Latest Posts › SCOTUS


Do-Gooders Won’t Take “No” For An Answer

About a month ago we posted an article on the dismissal of Consumer Watchdog’s appeal at the Court of Appeals for the Federal Circuit following a loss at the USPTO in an inter partes reexamination. Consumer Watchdog, Inc. had...more

12/3/2014 - Appeals Consumer Watchdog FOIA Inter Partes Review Proceedings Patents Petition for Writ of Certiorari Petitions for Review SCOTUS Stem cells USPTO WARF

Myriad - One Year Later

The Supreme Court decision last year on June 13, 2013 in Association of Molecular Pathology v. Myriad Genetics may have been a watershed moment for the biotechnology industry. So far the effects have been hard to detect, but...more

6/23/2014 - Ambry Biotechnology DNA Genetic Materials Myriad v Ambry Patent-Eligible Subject Matter Patents Roslin SCOTUS Section 101 Stem cells USPTO

The Curious Case Of Human Gene Patents

The U.S. Supreme Court heard oral arguments last month in the matter of Association for Molecular Pathology v. Myriad Genetics, a curious case that does not bode well for America’s biotechnology industry and could overturn 30...more

5/22/2013 - ACLU AMP v Myriad DNA Free Trade Agreement Human Genes Myriad Oral Argument Patents SCOTUS USPTO

3 Results
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.